MO11-1 Efficacy of durvalumab after chemoradiotherapy with daily low-dose carboplatin for unresectable locally advanced NSCLC

Category Primary study
JournalAnnals of Oncology
Year 2022
This article has no abstract
Epistemonikos ID: 1634e119a25dfa931ca316d55cc5688d06ce4771
First added on: Feb 14, 2025